2575 — Xuanzhu Biopharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$17.56bn
- HK$17.44bn
- CNY30.09m
Annual balance sheet for Xuanzhu Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 450 | 246 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 13.5 | 14.6 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 542 | 369 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 207 | 172 |
| Net Intangible Assets | ||
| Long Term Notes Receivable | ||
| Other Long Term Assets | ||
| Total Assets | 1,321 | 1,197 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 143 | 179 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 211 | 240 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 1,110 | 957 |
| Total Liabilities & Shareholders' Equity | 1,321 | 1,197 |
| Total Common Shares Outstanding |